HIV, AIDS, and zidovudine. 1992

R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
March 1992, Lancet (London, England),
R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
October 2010, The Indian journal of medical research,
R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
December 1988, Medizinische Monatsschrift fur Pharmazeuten,
R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
February 1989, Hospital practice (Office ed.),
R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
May 1987, The New Zealand medical journal,
R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
April 1993, The Journal of laboratory and clinical medicine,
R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
July 1998, Journal of neurology, neurosurgery, and psychiatry,
R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
January 1987, Nursing times,
R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
March 2013, The Cochrane database of systematic reviews,
R S Tedder, and M G Semple, and M Tenant-Flowers, and C Loveday
June 1988, AIDS (London, England),
Copied contents to your clipboard!